Your browser doesn't support javascript.
loading
The role of surface molecule CD229 in Multiple Myeloma.
Olson, Michael; Radhakrishnan, Sabarinath Venniyil; Luetkens, Tim; Atanackovic, Djordje.
Affiliation
  • Olson M; Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States.
  • Radhakrishnan SV; Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States.
  • Luetkens T; Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States.
  • Atanackovic D; Multiple Myeloma Program & Cancer Immunotherapy, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address: djordje.atanackovic@hci.utah.edu.
Clin Immunol ; 204: 69-73, 2019 07.
Article in En | MEDLINE | ID: mdl-30326256
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signaling Lymphocytic Activation Molecule Family / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signaling Lymphocytic Activation Molecule Family / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article